hyaluronic acid oral liposomal
Selected indexed studies
- Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation. (J Drug Target, 2021) [PMID:32997536]
- Inulin and hyaluronic acid-based oral liposome for enhanced photo-chemotherapy against orthotopic colon cancer and its reversal effects on tumor hypoxia and intestinal microbiota. (Int J Biol Macromol, 2025) [PMID:39952512]
- Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting. (Int J Biol Macromol, 2024) [PMID:39349339]
_Worker-drafted node — pending editorial review._
Connections
hyaluronic acid oral liposomal helps
Sources
- Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation. (2021) pubmed
- Inulin and hyaluronic acid-based oral liposome for enhanced photo-chemotherapy against orthotopic colon cancer and its reversal effects on tumor hypoxia and intestinal microbiota. (2025) pubmed
- Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting. (2024) pubmed
- The progress of hyaluronic acid's application in therapeutic delivery. (2025) pubmed
- Artificial Intelligence-Guided Optimization of Hyaluronic Acid-Coated Liposomal Linagliptin for Targeted Management of Polycystic Ovary Syndrome. (2026) pubmed
- Hyaluronic acid-conjugated lipid nanocarriers in advancing cancer therapy: A review. (2025) pubmed
- Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate. (2022) pubmed
- Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests. (2022) pubmed
- Macrophage-targeted Hyaluronic-acid Coated Liposomes Bearing Ursolic Acid for Visceral Leishmaniasis: In Vitro Characterisation and Pharmacokinetic Analysis. (2026) pubmed
- Triple-Cascade Responsive Pneumatic Nanomotor Enhance Cancer Immunotherapy by Oncolytic Virus-Triggered Pyroptosis. (2026) pubmed